Clinical Trials Logo

Clinical Trial Summary

This study aims to explore the clinical significance and feasibility of double site biopsy by analyzing the pathological characteristics and the incidence of main complications of CT guided puncture biopsy of lung and other parts coexisting lesions.


Clinical Trial Description

CT guided biopsy is minimally invasive, accurate and low cost. It is often used as an important diagnostic method when the clinical suspect of malignant disease or the treatment effect of the disease is not good. In patients with suspected malignant lung disease, metastasis of other parts of lung, pulmonary door, mediastinum, bone, and distant soft tissue may be combined at the same time. It is the key link of clinical work to evaluate the nature of these coexisting lesions accurately and choose appropriate treatment methods. At present, there is little clinical study on lung centered double site biopsy. This study aims to explore the clinical significance and feasibility of double site biopsy by analyzing the pathological characteristics and the incidence of main complications of CT guided puncture biopsy of lung and other parts coexisting lesions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04960631
Study type Observational
Source Peking University Third Hospital
Contact
Status Completed
Phase
Start date March 1, 2018
Completion date May 31, 2018

See also
  Status Clinical Trial Phase
Unknown status NCT01812876 - A Registry Study on Shenqifuzheng(a Chinese Medicine Injection)Used in Hospitals in China N/A